RHFI
AMGN icon

Reilly Herbert Faulkner III’s Amgen AMGN Stock Holding History

Reilly Herbert Faulkner III’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$8.25M Buy
33,152
+1,042
+3% +$249K 2.61% 24
2020
Q4 		$7.38M Buy
32,110
+1,401
+5% +$323K 2.43% 24
2020
Q3 		$7.8M Sell
30,709
-25
-0.1% -$6.19K 2.84% 16
2020
Q2 		$7.25M Buy
30,734
+472
+2% +$108K 2.88% 15
2020
Q1 		$6.13M Sell
30,262
-1,105
-4% -$241K 2.96% 15
2019
Q4 		$7.56M Sell
31,367
-1,193
-4% -$263K 3.06% 9
2019
Q3 		$6.3M Buy
32,560
+363
+1% +$69.7K 2.65% 19
2019
Q2 		$5.93M Buy
32,197
+1,861
+6% +$333K 2.59% 22
2019
Q1 		$5.76M Buy
30,336
+984
+3% +$188K 2.63% 20
2018
Q4 		$5.71M Sell
29,352
-166
-0.6% -$32.4K 3.1% 10
2018
Q3 		$6.12M Sell
29,518
-27
-0.1% -$5.32K 2.98% 13
2018
Q2 		$5.45M Buy
29,545
+268
+0.9% +$47.4K 2.97% 14
2018
Q1 		$4.99M Buy
29,277
+836
+3% +$153K 2.84% 16
2017
Q4 		$4.95M Buy
28,441
+17
+0.1% +$3.01K 2.69% 20
2017
Q3 		$5.3M Sell
28,424
-196
-0.7% -$34.7K 3.22% 7
2017
Q2 		$4.93M Buy
28,620
+621
+2% +$101K 3.08% 6
2017
Q1 		$4.59M Buy
27,999
+161
+0.6% +$26.8K 2.95% 15
2016
Q4 		$4.07M Buy
27,838
+905
+3% +$136K 2.87% 18
2016
Q3 		$4.49M Buy
26,933
+580
+2% +$98.1K 3.34% 7
2016
Q2 		$4.01M Buy
26,353
+594
+2% +$92.4K 2.94% 17
2016
Q1 		$3.86M Buy
25,759
+1
+0% +$149 2.86% 15
2015
Q4 		$4.18M Buy
25,758
+185
+0.7% +$29.1K 3.52% 4
2015
Q3 		$3.54M Buy
25,573
+139
+0.5% +$21.9K 3.14% 5
2015
Q2 		$3.9M Buy
25,434
+869
+4% +$139K 3.32% 3
2015
Q1 		$3.96M Buy
24,565
+604
+3% +$95.1K 3.35% 6
2014
Q4 		$3.82M Sell
23,961
-396
-2% -$61.7K 3.38% 4
2014
Q3 		$3.42M Buy
24,357
+243
+1% +$31.7K 3.36% 5
2014
Q2 		$2.85M Sell
24,114
-219
-0.9% -$25.4K 2.79% 19
2014
Q1 		$3M Buy
24,333
+349
+1% +$42.3K 2.98% 9
2013
Q4 		$2.74M Buy
+23,984
New +$2.73M 2.71% 20

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Reilly Herbert Faulkner III's AMGN Position: Q1 2021 in Review

Reilly Herbert Faulkner III increased its Amgen (AMGN) stake by 3.2% in Q1 2021, buying an estimated $249K and bringing the position to 33,152 shares worth $8.25M. The position accounts for 2.61% of the portfolio, ranked #24.

Reilly Herbert Faulkner III first reported a position in AMGN in Q4 2013 and has held it in 30 quarters since. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • Reilly Herbert Faulkner III held 33,152 shares of Amgen worth $8.25M as of Q1 2021.
  • Reilly Herbert Faulkner III bought 1,042 Amgen shares in Q1 2021, an estimated $249K.
  • Amgen made up 2.61% of Reilly Herbert Faulkner III's portfolio in Q1 2021, its #24 holding.
  • Reilly Herbert Faulkner III first reported a position in Amgen in Q4 2013 and has held it in 30 quarters since.
  • 2,218 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on Reilly Herbert Faulkner III's 13F filing for Q1 2021, filed 12 May 2021.